Search

Displaying results 7971 - 7980 of 10000 in total
  1. Drug

    Reltecimod

    go.drugbank.com/drugs/DB16687
    Investigational

    Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).

    Synonyms: D-alanyl-L-seryl-L-prolyl-L-methionyl-L-leucyl-L-valyl-L-alanyl-L-tyrosyl-L-aspartyl-D-alanine
  2. Drug

    Tebapivat

    go.drugbank.com/drugs/DB19338
    Investigational

    Tebapivat is under investigation in clinical trial NCT05490446 (A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-risk Myelodysplastic Syndromes (LR-MDS)).

    Synonyms: 6-[(6-aminopyridin-2-yl)methyl]-4-methyl-2-[(1H-pyrazol-3-yl)methyl]-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one
  3. Drug

    Glufosfamide

    go.drugbank.com/drugs/DB06177
    Investigational

  4. Drug

    Darinaparsin

    go.drugbank.com/drugs/DB06179
    Investigational

  5. Drug

    S-Hydroxycysteine

    go.drugbank.com/drugs/DB01915
    Experimental

    These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. … S-hydroxycysteine is a solid. This compound belongs to the alpha amino acids and derivatives.

  6. Drug

    Fominoben

    go.drugbank.com/drugs/DB08968
    ApprovedWithdrawn

    Fominoben is an antitussive agent.

  7. Drug

    Urethane

    go.drugbank.com/drugs/DB04827
    ApprovedWithdrawn

    Urethane, formerly marketed as an inactive ingredient in Profenil injection, was determined to be carcinogenic and was removed from the Canadian, US, and UK markets in 1963.

  8. Drug

    Ormeloxifene

    go.drugbank.com/drugs/DB13310
    Experimental

    activity in the uterus and breast. … [A251450,A251460] Ormeloxifene is marketed in India as a racemic mixture of the l- (levormeloxifene) and d-isomers (d-ormeloxifene) of _trans_-ormeloxifene.

  9. Drug

    Mesenchymal stem cell-derived exosomes

    go.drugbank.com/drugs/DB24445
    Investigational

    Mesenchymal Stem Cell-Derived Exosomes is a biologic drug. … Mesenchymal Stem Cell-Derived Exosomes is under investigation in clinical trial NCT07183384 (MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction).

  10. Drug

    CRTKVA11-03

    go.drugbank.com/drugs/DB33965
    Experimental

    CRTKVA11-03 is a biologic drug. CRTKVA11-03 is under investigation in clinical trial NCT07826585 (Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection).